Journal of the American Society of Hypertension
Volume 1, Issue 1 , Pages 56-67 , January 2007

The vascular phenotypes in hypertension: Relation with the natural history of hypertension

  • Ernesto L. Schiffrin, MD, PhD, FRCPC

      Affiliations

    • Corresponding Author InformationCorresponding author: Ernesto L. Schiffrin, MD, PhD, FRCPC, Sir Mortimer B. Davis Jewish General Hospital, B-127, 3755 Ch. Côte Ste-Catherine, Montreal, Quebec, Canada H3T 1E2, Tel: 514-340-7538; fax: 514-340-7539.

Received 10 November 2006 ,Accepted 10 November 2006.

References 

  1. Safar ME, Boudier HS. Vascular development, pulse pressure, and the mechanisms of hypertension. Hypertension. 2005;46:205–209
  2. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor. Hypertension. 2005;46:454–462
  3. Safar ME, Girerd X, Laurent S. Structural changes of large conduit arteries in hypertension. J Hypertens. 1996;14:545–555
  4. Mitchell GF, Lacourcière Y, Ouellet JP, et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation. 2003;108:1592–1598
  5. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107:2864–2869
  6. O’Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45:652–658
  7. Schiffrin EL. Vascular stiffening and arterial compliance: implications for systolic blood pressure. Am J Hypertens. 2004;17:39S–48S
  8. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
  9. Cohn JN. Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation. 2006;113:601–603
  10. Dernellis J, Panaretou M. Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects. Hypertension. 2005;45:426–431
  11. Liao DP, Arnett DK, Tyroler HA, et al. Arterial stiffness and the development of hypertension: the ARIC Study. Hypertension. 1999;34:201–206
  12. Chobanian A. Adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension. 1990;15:666–674
  13. Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction (Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension). J Hypertens. 2005;23:7–17
  14. Boumaza S, Arribas SM, Osborne-Pellegrin M, et al. Fenestrations of the carotid internal elastic lamina and structural adaptation in stroke-prone spontaneously hypertensive rats. Hypertension. 2001;37:1101–1107
  15. Laurent S. Arterial wall hypertrophy and stiffness in essential hypertensive patients. Hypertension. 1995;26:355–362
  16. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension. 2005;45:1050–1055
  17. Mitchell GF, DeStefano AL, Larson MG, et al. Heritability and a genome-wide linkage scan for arterial stiffness, wave reflection, and mean arterial pressure: the Framingham Heart Study. Circulation. 2005;112:194–199
  18. DeStefano AL, Larson MG, Mitchell GF, et al. Genome-wide scan for pulse pressure in the National Heart, Lung, and Blood Institute’s Framingham Heart Study. Hypertension. 2004;44:152–155
  19. Lajemi M, Labat C, Gautier S, et al. Angiotensin II type 1 receptor -153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens. 2001;19:407–413
  20. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;61:181–186
  21. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension. 1993;21:391–397
  22. Mulvany MJ, Baumbach GL, Aalkjaer C, et al. Vascular remodeling. Hypertension. 1996;28:505–506
  23. Schiffrin EL, Deng LY, Larochelle P. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med. 1993;16:177–186
  24. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens. 2004;17:1192–1200
  25. Rizzoni D, Porteri E, Castellano M, et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension. 1996;28:785–790
  26. Rizzoni D, Porteri E, Guelfi D, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation. 2001;103:1238–1244
  27. Endemann D, Pu Q, De Ciuceis C, et al. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension. 2004;43:399–404
  28. Rizzoni D, Porteri E, Giustina A, et al. Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension. 2004;43:561–565
  29. Amiri F, Virdis A, Neves MF, et al. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation. 2004;110:2233–2240
  30. Schiffrin EL, Larivière R, Li JS, Sventek P. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J Vasc Res. 1996;33:235–248
  31. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension. 1994;24:183–188
  32. D’Uscio LV, Barton M, Shaw S, Moreau P, Lüscher TF. Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade. Hypertension. 1997;30:905–911
  33. Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol. 2004;287:H435–H446
  34. Mulvany MJ, Baandrup U, Gundersen HJ. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional disector. Circ Res. 1985;57:794–800
  35. Lee RMKW, Garfield RE, Forrest JB, Daniel EE. Morphometric study of structural changes in the mesenteric blood vessels of spontaneously hypertensive rats. Blood Vessels. 1983;20:57–71
  36. Korsgaard N, Aalkjær C, Heagerty AM, Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension. 1993;22:523–526
  37. Rizzoni D, Porteri E, Guefi D, et al. Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension. 2000;35:931–935
  38. DeBlois D, Tea BS, Dam TV, Tremblay J, Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension. 1997;29:340–349
  39. Dickhout JG, Lee RM. Apoptosis in the muscular arteries from young spontaneously hypertensive rats. J Hypertens. 1999;17:1413–1419
  40. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001;38:581–587
  41. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension. 2000;36:312–318
  42. Intengan HD, Deng LY, Li JS, Schiffrin EL. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension. 1999;33:569–574
  43. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation. 1999;100:2267–2275
  44. Baumbach GL, Hajdu MA. Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats. Hypertension. 1993;21:816–826
  45. Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin EL. Endothelin antagonism onaldosterone-induced oxidative stress and vascular remodeling. Hypertension. 2003;42:49–55
  46. Neves MF, Virdis A, Schiffrin EL. Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism. J Hypertens. 2003;21:189–198
  47. Bakker ENTP, Van der Meulen ET, Van den Berg BM, Everts V, Spaan JAE, VanBavel E. Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res. 2002;39:12–20
  48. Bakker ENTP, Buus CL, VanBavel E, Mulvany MJ. Activation of resistance arteries with endothelin-1: from vasoconstriction to functional adaptation and remodeling. J Vasc Res. 2004;41:174–182
  49. Brassard P, Amiri F, Schiffrin EL. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Hypertension. 2005;46:598–606
  50. Brassard P, Amiri F, Thibault G, Schiffrin EL. Role of angiotensin type-1 and angiotensin type-2 receptors in the expression of vascular integrins in angiotensin II-infused rats. Hypertension. 2006;47:122–127
  51. Bakker ENTP, Buus CL, Spaan JAE, et al. Small artery remodeling depends on tissue-type transglutaminase. Circ Res. 2005;96:119–126
  52. Langille BL, Dajnowiec D. Cross-linking vasomotor tone and vascular remodeling: a novel function for tissue transglutaminase?. Circ Res. 2005;96:9–11
  53. De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol. 2005;25:2106–2113
  54. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest) form of target organ damage in mild essential hypertension. J Hypertens. 2001;19:921–930
  55. Rizzoni D, Porteri E, Boari GE, et al. Prognostic significance of small-artery structure in hypertension. Circulation. 2003;108:2230–2235
  56. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19–26
  57. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and in increased number of smooth muscle cell layers. Circ Res. 1978;43:854–864
  58. Folkow B, Hallback M, Lundgren Y, Sivertsson R, Weiss L. Importance of adaptive changes in vascular design for establishment of primary hypertension, studied in man and in spontaneously hypertensive rats. Circ Res. 1973;32/33(suppl I):I12–I16
  59. Baubach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13:968–972
  60. Izzard AS, Bund SJ, Heagerty AM. Increased wall-lumen ratio of mesenteric vessels from the spontaneously hypertensive rat is not associated with increased contractility under isobaric conditions. Hypertension. 1996;28:604–608
  61. Izzard AS, Heagerty AM, Leenen FHH. The amplifier hypothesis: permission to dissent?. J Hypertens. 1999;17:1667–1669
  62. Izzard AS, Bund SJ, Heagerty AM. Myogenic tone in mesenteric arteries from spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 1996;270:H1–H6
  63. Izzard AS, Heagerty AM. Impaired flow-dependent dilatation in distal mesenteric arteries from the spontaneously hypertensive rat. J Physiol. 1999;518:239–245
  64. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation. 2002;106:3037–3043
  65. Matrougui K, Schiavi P, Guez D, Henrion D. High sodium intake decreases pressure-induced (myogenic) tone and flow-induced dilation in resistance arteries from hypertensive rats. Hypertension. 1998;32:176–179
  66. Deng LY, Li JS, Schiffrin EL. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci (Lond). 1995;88:611–622
  67. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983–1992
  68. Schiffrin EL. A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol. 2001;38:S3–S6
  69. Schiffrin EL, Deng LY, Sventek P, Day R. Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension. J Hypertens. 1997;15:57–63
  70. Al Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948–954
  71. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191–196
  72. Britten MB, Zeiher AM, Schächinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coronary Artery Dis. 2004;15:259–264
  73. Rizzoni D, Porteri E, Guelfi D, et al. Endothelial dysfunction in small resistance arteries of patients with non-insulin-dependent diabetes mellitus. J Hypertens. 2001;19:913–919
  74. DeBlois D, Lombardi DM, Su EJ, Clowes AW, Schwartz SM, Giachelli CM. Angiotensin II induction of osteopontin expression and DNA replication in rat arteries. Hypertension. 1996;28:1055–1063
  75. Lin ZH, Fukuda N, Jin XQ, et al. Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 2004;44:42–47
  76. Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111:1201–1209
  77. Callera GE, Montezano ACI, Yogi A, et al. c-src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats. Hypertension. 2005;46:1032–1038
  78. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension. 2004;44:248–252
  79. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003;42:1075–1081
  80. Cruzado MC, Risler NR, Miatello RM, Yao GY, Schiffrin EL, Touyz RM. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. Am J Hypertens. 2005;18:81–87
  81. Touyz RM, Yao G, Schiffrin EL. c-src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2003;23:981–987
  82. Touyz RM, Yao G, Quinn MT, Pagano PJ, Schiffrin EL. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol. 2005;25:512–518
  83. Landmesser U, Cai H, Dikalov S, et al. Role of p47phox in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40:511–515
  84. Weber DS, Rocic P, Mellis AM, et al. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2005;288:H37–H42
  85. Dikalova A, Clempus R, Lassegue B, et al. Nox1 Overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation. 2005;112:2276–2668
  86. Lee DL, Webb RC, Jin LM. Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. Hypertension. 2004;44:796–799
  87. Seko T, Ito M, Kureishi Y, et al. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res. 2003;92:411–418
  88. Ohtsu H, Suzuki H, Nakashima H, et al. Angiotensin II signal transduction through small GTP-binding proteins: mechanism and significance in vascular smooth muscle cells. Hypertension. 2006;48:534–540
  89. Savoia C, Tabet F, Yao GY, Schiffrin EL, Touyz RM. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens. 2005;23:1037–1045
  90. Touyz RM, He G, El Mabrouk M, Schiffrin EL. p38 MAP kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension. 2001;37:574–580
  91. El Mabrouk M, Diep QN, Benkirane K, Touyz RM, Schiffrin EL. SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension. Am J Physiol Heart Circ Physiol. 2004;286:H1954–H1962
  92. Brewster LM, Mairuhu G, Bindraban NR, Koopmans RP, Clark JF, van Montfrans GA. Creatine kinase activity is associated with blood pressure. Circulation. 2006;114:2034–2039
  93. Wesselman JPM, Kuijs R, Hermans JJR, et al. Role of the Rhoa/Rho kinase system in flow-related remodeling of rat mesenteric small arteries in vivo. J Vasc Res. 2004;41:277–290
  94. De Mey JGR, Schiffers PM, Hilgers RHP, Sanders MMW. Toward functional genomics of flow-induced outward remodeling of resistance arteries. Am J Physiol Heart Circ Physiol. 2005;288:H1022–H1027
  95. Durier S, Fassot C, Laurent S, et al. Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation. 2003;108:1845–1851
  96. Rudnichi A, Safar ME, Lajemi M, Benetos A. Gene polymorphisms of the renin-angiotensin system and age-related changes in systolic and diastolic blood pressure in subjects with hypertension. Am J Hypertens. 2004;17:321–327
  97. Safar ME, Lajemi M, Rudnichi A, Asmar R, Benetos A. Angiotensin-converting enzyme D/I gene polymorphism and age-related changes in pulse pressure in subjects with hypertension. Arterioscler Thromb Vasc Biol. 2004;24:782–786
  98. Safar ME, Cattan V, Lacolley P, et al. Aldosterone synthase gene polymorphism, stroke volume, and age-related changes in aortic pulse wave velocity in subjects with hypertension. J Hypertens. 2005;23:1159–1166
  99. Lajemi M, Gautier S, Poirier O, et al. Endothelin gene variants and aortic and cardiac structure in never-treated hypertensives. Am J Hypertens. 2001;14:755–760
  100. Franklin SS, Pio JR, Wong ND, et al. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation. 2005;111:1121–1127
  101. James MA, Watt PAC, Potter JF, Thurston H, Swales JD. Pulse pressure and resistance artery structure in the elderly. Hypertension. 1995;26:301–306
  102. Mitchell GF, Vita JA, Larson MG, et al. Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study. Circulation. 2005;112:3722–3728
  103. Mulvany MJ. Resistance vessel structure and the pathogenesis of hypertension. J Hypertens. 1993;11(suppl 5):S7–S12
  104. Crowley SD, Gurley SB, Oliverio MI, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest. 2005;115:1092–1099
  105. Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685–1697

 The work was supported by the Canadian Institutes of Health Research grants 13570, 37917, and a group grant to the Multidisciplinary Research Group on Hypertension of the Institut de Recherches Cliniques de Montréal (IRCM).Conflict of interest: none.

PII: S1933-1711(06)00003-9

doi: 10.1016/j.jash.2006.11.003

Journal of the American Society of Hypertension
Volume 1, Issue 1 , Pages 56-67 , January 2007

Article Tools

* Image Usage & Resolution